# CR161 Strategy Admission Evidence Pipeline Hardening Verification Report

## Summary

| Field | Value |
|---|---|
| CR | `CR-161` |
| Stage | `CP7` |
| Verification mode | `review-only / static contract verification` |
| Execution actor | `host-orchestrator-inline` fallback after `meta-qa-critical` agent handle was no longer available |
| Decision | `PASS_WITH_RISK` |
| Checked at | `2026-07-10T06:20:54+08:00` |

CP7 verified the approved CR161 design-only slice. The evidence contract is reviewable, fail-closed, integrated through CR151/CR154 refs and summaries, and explicit about what remains unavailable. The result is `PASS_WITH_RISK` because this slice validates design and contract semantics only; it does not compute FDR/PBO/DSR, fold-level OOS, real TCA, market impact, capacity sizing, liquidity sizing, or alpha decay.

## Verification Scope

| In Scope | Result |
|---|---|
| Seven-object evidence coverage matrix | PASS |
| `typed_unavailable` fail-closed claim-tier semantics | PASS |
| CR151/CR154 integration without a parallel gate family | PASS |
| CR155 blocked negative regression expectation | PASS |
| CP4/CP5/CP6 N/A route under design-only approval | PASS |
| Follow-up split `FU-CR161-001` through `FU-CR161-005` | PASS |
| Authorization boundary and forbidden operation check | PASS |

| Out of Scope | Reason |
|---|---|
| FDR / WRC-SPA / PBO / DSR computation | Deferred to `FU-CR161-002` and separate implementation authorization. |
| Walk-forward fold metric computation | Deferred to `FU-CR161-003`. |
| Real TCA, market impact, cost calibration | Deferred to `FU-CR161-004` and separate data/runtime authorization. |
| Capacity/liquidity sizing and alpha decay | Deferred to `FU-CR161-005`. |
| Research-engine trial lineage instrumentation | Deferred to `FU-CR161-001`. |
| Source/test/schema/checker implementation | Not authorized by CP3 approval. |

## Traceability Matrix

| Requirement | Evidence | Verification Result |
|---|---|---|
| Explicit 7-object coverage | `docs/design/HLD-STRATEGY-ADMISSION-EVIDENCE-PIPELINE-HARDENING.md#8-seven-object-evidence-coverage-matrix` | PASS |
| `typed_unavailable` blocks mandatory higher-tier claims | HLD §7 and §9 | PASS |
| Current slice truthfully excludes computation | HLD §1, §5, §8, §17, §20 | PASS |
| CR151/CR154 integration only through refs/summaries | HLD §8, §10, §11; ADR-CR161-003 | PASS |
| CR155 remains blocked negative regression | HLD §13, §23, §24; ADR-CR161-004 | PASS |
| CP4/CP5/CP6 are N/A, not waived | `process/checks/CP4-CR161-STORY-DAG-PARALLEL-SAFETY.result.json`, `process/checks/CP5-CR161-LLD-DESIGN-EVIDENCE.result.json`, `process/checks/CP6-CR161-IMPLEMENTATION-DONE.result.json` | PASS |
| No unauthorized operation | CP3 checkpoint, CP7 context, dispatch ledger, static command set | PASS |

## Design Contract Verification

| Contract | Source | Result | Notes |
|---|---|---|---|
| `ExperimentFamilyManifest` covers trial lineage and trial count | HLD §8 | PASS | Current status can be `typed_unavailable`; no historical inference is allowed. |
| `MultipleTestingEvidence` covers raw/adjusted p-values and FDR/BH | HLD §8 | PASS | Missing evidence blocks significance claims. |
| `DataSnoopingEvidence` covers WRC/SPA-style corrections | HLD §8 | PASS | Missing evidence blocks data-snooping-adjusted robustness claims. |
| `OverfitRiskEvidence` covers PBO/CSCV and DSR/deflation | HLD §8 | PASS | Missing evidence blocks robustness and paper/production claims. |
| `WalkForwardEvidence` covers OOS folds, split, purge/embargo and leakage | HLD §8 | PASS | Current slice does not compute folds. |
| `EconomicCostEvidence` covers costs, slippage and impact boundary | HLD §8 | PASS | Current slice does not implement real TCA or cost calibration. |
| `CapacityLiquidityEvidence` covers capacity, ADV, liquidity and alpha decay | HLD §8 | PASS | Current slice does not implement sizing. |

## Commands And Evidence

| Command | Result | Summary |
|---|---|---|
| `rg -n "ExperimentFamilyManifest|MultipleTestingEvidence|DataSnoopingEvidence|OverfitRiskEvidence|WalkForwardEvidence|EconomicCostEvidence|CapacityLiquidityEvidence" docs/design/HLD-STRATEGY-ADMISSION-EVIDENCE-PIPELINE-HARDENING.md docs/design/ARCHITECTURE-DECISION-STRATEGY-ADMISSION-EVIDENCE-PIPELINE-HARDENING.md` | PASS | All seven evidence objects are present in HLD section 8 and follow-up sections. |
| `rg -n "paper_candidate=true|paper_candidate: true|production_like=true|production_ready=true|runtime_authorized=true|simulation_ready=true|FDR proven|PBO proven|DSR proven|real TCA proven|capacity-ready|production-ready|live-ready" ...` | PASS_WITH_NOTE | Only blocked wording examples were found; no positive readiness assignment was found. |
| `uv run --python 3.11 python -m json.tool process/checks/CP3-CR161-STRATEGY-ADMISSION-EVIDENCE-PIPELINE-HARDENING-HLD-CONSISTENCY.result.json` | PASS | Upstream CP3 result JSON parses. |
| `uv run --python 3.11 python -m json.tool process/checks/CP4-CR161-STORY-DAG-PARALLEL-SAFETY.result.json` | PASS | CP4 N/A result JSON parses. |

## Boundary Check

| Boundary | Result |
|---|---|
| Source/test implementation | Not executed |
| Schema/checker implementation | Not executed |
| Research-engine instrumentation | Not executed |
| Real lake read/write | Not executed |
| NAS operation | Not executed |
| Provider fetch | Not executed |
| Credential/env/secret read | Not executed |
| Broker/trading/runtime operation | Not executed |
| Simulation/paper/live run | Not executed |
| External framework clone/install/run | Not executed |
| Git remote write | Not executed |
| Release/publish | Not executed |

## Residual Risks

| Risk | Severity | Status | CP8 Handling |
|---|---|---|---|
| `R-CR161-STATIC-CONTRACT-MISREAD-AS-COMPUTED-PROOF` | HIGH | controlled | CP8 must state design-only and no computed proof. |
| `R-CR161-TRIAL-LINEAGE-SOURCE` | MEDIUM | follow-up required | Track `FU-CR161-001`. |
| `R-CR161-CR155-HISTORICAL-EVIDENCE-GAP` | HIGH | controlled | Keep CR155 negative regression only. |
| `R-CR161-RESEARCH-ENGINE-INSTRUMENTATION-SCOPE-CREEP` | MEDIUM | controlled | Follow-up CR required before implementation. |
| `R-CR161-RUNTIME-AUTHORIZATION-LEAK` | HIGH | controlled | CP8 must preserve explicit non-authorization wording. |
| `R-CR161-VERIFICATION-INDEPENDENCE-GAP` | HIGH | accepted only through CP8 waiver | The dispatch ledger proves the failed handoff and inline fallback, not independent QA completion. CP8 must explicitly accept a time-bounded waiver or require a fresh independent meta-qa review. |

## Decision

`PASS_WITH_RISK`.

Proceed to CP8 release readiness only with explicit design-only risk acceptance and an explicit verification-independence waiver. Do not represent CR161 as independently QA-verified, as implementing computable statistical evidence, or as runtime ready.
